home / stock / vrca / vrca news

VRCA News and Press, Verrica Pharmaceuticals Inc. From 12/15/23

Stock Information
Company Name: Verrica Pharmaceuticals Inc.
Stock Symbol: VRCA
Market: NASDAQ
Website: verrica.com
Menu
VRCA VRCA Quote VRCA Short VRCA News VRCA Articles VRCA Message Board
Get VRCA Alerts

News, Short Squeeze, Breakout and More Instantly...
VRCA - Why Is Verrica Pharmaceuticals (VRCA) Stock Up 40% Today?

2023-12-15 13:49:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Verrica Pharmaceuticals (NASDAQ: VRCA ) skyrocketed on Friday thanks to positive late-stage clinical trial results. Specifically, Verrica — along with its developme...
VRCA - BATL, and TANH among mid-day movers

2023-12-15 13:25:40 ET Gainers: Getaround ( GETR ) +116% . Battalion Oil Corp ( BATL ) +82% . La Rosa Holdings Corp. ( LRHC ) +45% . Verrica Pharmaceuticals ( VRCA ) +37% . Bruush Oral Care ( BRSH ) +36% . NCS Multistage Hold...

VRCA - Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Near the Top of Equities by Percentage Gain on 12/15

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) is one of today's top gainers. The company's shares have moved 4.6% on the day to $3.52. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The ...

VRCA - Positive Top-line Phase 3 Trial Results could Propel Listing to Refill Recent Gap

2023-12-15 11:03:39 ET DENVER, Colo., Dec 15, 2023 ( www.247marketnews.com )- Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) has been marching higher, since reporting, this morning, that its development and commercialization partner, Torii Pharmaceutical, reported positive top-line results...
VRCA - Verrica stock rallies 55% amid positive Phase 3 results for skin drug

2023-12-15 10:47:09 ET More on Verrica Pharmaceuticals Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals Historical earnings data for Verrica Pharmaceuticals Financial informati...

VRCA - Myomo, Aileron Therapeutics among healthcare movers

2023-12-15 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Myomo, Aileron...

VRCA - GOTU, SMR and LDI are among pre market gainers

2023-12-15 08:46:33 ET Aurora Technology Acquisition  ( ATAK ) +50% . Brilliant Acquisition  ( BRLI ) +27% . Ikena Oncology ( IKNA ) +24% . SportsMap Tech Acquisition  ( SMAP ) +14% . Pineapple Financial  ( PAPL ) +1%...
VRCA - Verrica Pharmaceuticals' Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan

WEST CHESTER, Pa., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that its developm...

VRCA - Verrica Pharmaceuticals Announces Presentation at the Jefferies Global Healthcare Conference in London

WEST CHESTER, Pa., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced Ted White, Verric...

VRCA - Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript

2023-11-09 09:57:02 ET Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Conference Call November 09, 2023 08:30 AM ET Company Participants Kevin Gardner - LifeSci Advisors Ted White - President & Chief Executive Officer\ Joe Bonaccorso - Chief Commercial ...
Previous 10 Next 10